ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.098,09
-0,50%
S&P 500
5.277,51
0,80%
US Dollar vs BRL
5,2463
0,00%
Bitcoin
67.835,25
0,16%
Brent Oil
81,295
0,00%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. App Pharmaceuticals (MM) (APPX)

  7. App Pharmaceuticals (MM) (APPX) Notícias

APPX

App Pharmaceuticals (MM) (APPX)

App Pharmaceuticals (MM)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:APPX
DataHoraFonteTítuloCódigoCompanhia
13/11/201816:13GlobeNewswire Inc.APPx Group Holdings, Inc. Signs LOI to Acquire Cimtel (Quebec) Inc.NASDAQ:APPXApp Pharmaceuticals (MM)
06/11/201812:49GlobeNewswire Inc.APPx Group Holdings, Inc. Trading on CSE Under Symbol “APPX”NASDAQ:APPXApp Pharmaceuticals (MM)
10/09/200812:17Edgar (US Regulatory)App Pharmaceuticals, Inc.-Filing of certain prospectuses and communications for business combination transactions (425)NASDAQ:APPXApp Pharmaceuticals (MM)
05/09/200813:56Edgar (US Regulatory)App Pharmaceuticals, Inc. - Current report filing (8-K)NASDAQ:APPXApp Pharmaceuticals (MM)
03/09/200817:05PR Newswire (US)Mergent, Inc. Announces Changes to the HealthShares(TM) Cancer Index, Composite Index, Dermatology and Wound Care Index, EnablinNASDAQ:APPXApp Pharmaceuticals (MM)
21/08/200807:01Edgar (US Regulatory)App Pharmaceuticals, Inc. - Information Statement - Merger or Acquisition (definitive) (DEFM14C)NASDAQ:APPXApp Pharmaceuticals (MM)
18/08/200817:59Business WireAPP Pharmaceuticals Receives Manufacturing Approval for Three Product Codes of Heparin at Puerto Rico FacilityNASDAQ:APPXApp Pharmaceuticals (MM)
18/08/200807:02Edgar (US Regulatory)App Pharmaceuticals, Inc. - Information Statements (revised) (PRER14C)NASDAQ:APPXApp Pharmaceuticals (MM)
04/08/200817:28Edgar (US Regulatory)App Pharmaceuticals, Inc. - Quarterly Report (10-Q)NASDAQ:APPXApp Pharmaceuticals (MM)
01/08/200807:15Edgar (US Regulatory)App Pharmaceuticals, Inc. - Information Statement - Merger or Acquisition (preliminary) (PREM14C)NASDAQ:APPXApp Pharmaceuticals (MM)
31/07/200821:13Business WireAPP Pharmaceuticals Reports 2008 Second Quarter Net Revenues of $198 Million, Operating Income of $53 MillionNASDAQ:APPXApp Pharmaceuticals (MM)
24/07/200817:35Business WireAPP Pharmaceuticals Announces Date for 2008 Second Quarter Financial Results and Investor Conference CallNASDAQ:APPXApp Pharmaceuticals (MM)
10/07/200813:01Edgar (US Regulatory)App Pharmaceuticals, Inc. - Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:APPXApp Pharmaceuticals (MM)
08/07/200809:30MarketwiredMarket Pulse Breaking News Alert for Tuesday, July 8, 2008: PRRY -- Planet Resource Recovery Receives Significant Purchase OrderNASDAQ:APPXApp Pharmaceuticals (MM)
03/07/200809:00Business WireAPP Pharmaceuticals Receives Final Approvals for Additional Dosages of Granisetron Hydrochloride Injection, USPNASDAQ:APPXApp Pharmaceuticals (MM)
30/06/200817:53Edgar (US Regulatory)App Pharmaceuticals, Inc. - Annual Report of Employee Stock Plans (11-K)NASDAQ:APPXApp Pharmaceuticals (MM)
02/06/200811:59Business WireAPP Pharmaceuticals Launches Enhanced Labeling for Heparin Sodium Injection, USPNASDAQ:APPXApp Pharmaceuticals (MM)
15/05/200807:55Business WireAPP Pharmaceuticals Provides Update on Issues Related to Heparin Crisis and Actions to Ensure Uninterrupted Safe SupplyNASDAQ:APPXApp Pharmaceuticals (MM)
08/05/200817:08Edgar (US Regulatory)App Pharmaceuticals, Inc. - Initial Statement of Beneficial Ownership (3)NASDAQ:APPXApp Pharmaceuticals (MM)
08/05/200809:05Business WireAPP Pharmaceuticals Reports 2008 First Quarter Net Revenues of $148 Million, Gross Profit of $70 MillionNASDAQ:APPXApp Pharmaceuticals (MM)
01/05/200809:00Business WireAPP Pharmaceuticals Announces Date for 2008 First Quarter Financial Results and Investor Conference CallNASDAQ:APPXApp Pharmaceuticals (MM)
30/04/200821:16Business WireAPP Pharmaceuticals Names Thomas H. Silberg Chief Executive Officer; Appoints Richard J. Tajak Chief Financial OfficerNASDAQ:APPXApp Pharmaceuticals (MM)
29/04/200818:32Edgar (US Regulatory)App Pharmaceuticals, Inc. - Amended Annual Report (10-K/A)NASDAQ:APPXApp Pharmaceuticals (MM)
21/04/200809:00Business WireAPP Pharmaceuticals Receives FDA Approval for Colistimethate For Injection, USPNASDAQ:APPXApp Pharmaceuticals (MM)
25/03/200809:00Business WireAPP Pharmaceuticals Launches Cefepime Hydrochloride for InjectionNASDAQ:APPXApp Pharmaceuticals (MM)
17/03/200818:30Edgar (US Regulatory)App Pharmaceuticals, Inc. - Annual Report (10-K)NASDAQ:APPXApp Pharmaceuticals (MM)
14/03/200817:39Edgar (US Regulatory)App Pharmaceuticals, Inc. - Statement of Ownership (SC 13G)NASDAQ:APPXApp Pharmaceuticals (MM)
07/03/200810:05Business WireAPP Pharmaceuticals Reports Record Net Revenues of $647 Million and Gross Profit of $315 Million from Continuing Operations in 2NASDAQ:APPXApp Pharmaceuticals (MM)
28/02/200818:30Business WireAPP Pharmaceuticals Announces Date for Fourth Quarter and Full-Year Financial Results and Investor Conference CallNASDAQ:APPXApp Pharmaceuticals (MM)
28/02/200818:17Edgar (US Regulatory)App Pharmaceuticals, Inc. - Notification that Annual Report will be submitted late (NT 10-K)NASDAQ:APPXApp Pharmaceuticals (MM)
 Apresentando as notícias mais relevantes sobre:NASDAQ:APPX

Seu Histórico Recente

COIN
XLMBTC
Stellar Lumens
BOV
PETR3
PETROBRAS ON
COIN
BRAZBTC
Brazio
BOV
USIM5
USIMINAS PNA
BOV
ELET3
ELETROBRAS ON
BOV
GFSA3
GAFISA ON
EU
PX1
CAC 40
COIN
XRPBTC
Ripple
BOV
BBAS3
BANCO DO BRASIL ON
BOV
ITSA4
ITAUSA PN
COIN
ADABTC
Cardano
NYSE
GGB
Gerdau
BOV
IBOV
Índice Bovespa
NYSE
PBR.A
Petroleo Brasileiro ADR
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados